To investigate the association between hysterectomy and thyroid cancer subtypes based on histopathology. They did a nationwide, population-based, cohort study from 1973 to 2009 in Sweden. All women above 18 years of age during the period between January 1, 1973 and December 31, 2009 from the Register of Population (n 5 5.704,202) were identified as the study population. Individual case ascertainment of primary thyroid cancer subtypes were restricted to 1993-2009 based on histological pathologic-anatomical-diagnosis from the Cancer Register. Thyroid cancer subtypes were categorized based on histological morphology as: papillary, follicular and others (including anaplastic and medullary thyroid carcinoma). Information on benign hysterectomy derived from the Swedish Inpatient Register. Women with a hysterectomy (exposed) were compared with women not having had a hysterectomy (unexposed) using Cox's proportional hazard ratios (HRs). The adjusted HR for papillary thyroid cancer was significantly increased in exposed as compared with unexposed women (HR 1.70, 95% CI 1.04-2.79). There was no significant association between hysterectomy and follicular carcinoma or other thyroid cancers. There was a clear shift in the occurrence of thyroid cancer toward a lower attained age at the time of diagnosis among the exposed but no significant difference in overall survival when comparing exposed and unexposed (HR 1.02, 95% CI 0.48-2.16) Hysterectomy was associated with an increased risk for subsequent papillary thyroid cancer and diagnosis at a younger age compared with women not having had a hysterectomy but there were no differences in survival.
Introduction
Thyroid cancer is the most common malignancy of the endocrine system and represents 3.8% of all new cancer cases in the United States and industrialized countries.
1 Incidence rates of thyroid cancer have increased considerably during the last two decades, 2 and has a peak incidence in premenopausal women. 1 There is no clear evidence of an association between reproductive or hormonal factors and thyroid cancer. 3 Nonetheless it is biologically plausible that gender specific risk factors play an important role in the development of thyroid cancer given that it is threefold as common in women as in men. 4 Epidemiological studies support the role of hysterectomy as a risk factor for thyroid cancer, [5] [6] [7] [8] [9] although results are somewhat ambigous. 10 Methodological shortcomings including small number of cases, retrospective data collection, short follow-up times and the inability to differentiate between thyroid cancer subtypes, may to some extent explain the inconsistencies of previous studies. Hysterectomy is the most common major gynecologic surgical procedure worldwide and in the United States approximately 600,000 procedures are performed annually. 11 Other than its role in human reproduction, the uterus may influence the synthesis and release of several non-steroidal substances such as substance P and vasoactive peptides, [12] [13] [14] which has been implicated in various carcinogenic pathways.
Using nationwide registers based on the International Classification of Diseases (ICD) we have previously reported that hysterectomy for benign indications is associated with an increased overall risk for thyroid cancer. 15 In the present study we used histopathology reports for individual case ascertainment to further investigate the association between hysterectomy and thyroid cancer subtypes in a populationbased cohort of women.
Methods

Data sources
The individually unique national registration number, assigned to all individuals at birth or immigration, allows for unambiguous record linkage across all nationwide registers in Sweden. The Swedish Inpatient Register achieved complete national coverage in 1987 and contains data on individual hospital discharges. Each inpatient discharge record contains (i) dates of hospital admission and discharge; (ii) up to 22 discharge diagnoses, coded according to ICD revisions 7 through 10 and (iii) up to 12 operation codes from the Swedish Classification of Operations and Major Procedures. The register has a less than 1% yearly loss to registration and correct coding for surgical procedures is achieved in 98% of cases. The Swedish Medical Birth Register includes prospectively collected information during pregnancy, delivery and the neonatal period on virtually all births in Sweden since 1973. The Swedish Education Register includes level of education for all Swedish residents of age . The Register of Population includes information on dates of birth, death, emigration and immigration of all Swedish residents. The Cause of Death Register includes information on date and cause of death on all Swedish residents with a completeness exceeding 99%. This study was approved by the Research Ethics Committee at Karolinska Institutet, Stockholm, Sweden, and conforms to the STROBE guidelines for reporting observational studies (www.strobe-statement.org).
Study population
We identified as our study population all women above 18 years of age during the period between January 1, 1973 and December 31, 2009 from the Register of Population (n 5 5.704,202). Women were subsequently excluded from analysis if they had any gynecological surgical procedure before entering the cohort (n 5 9,381), if they had any primary cancer before entering the cohort (n 5 75,311), if they had other inconsistencies in their data (n 5 14,635) and if they emigrated out of Sweden before entering the cohort (n 5 224,993).
Exposure and covariates
We identified individual records of hysterectomy in the Swedish Inpatient Register using the Women undergoing hysterectomy contributed persontime to the exposed cohort from the time of hysterectomy until first occurrence of any cancer, death, emigration or end of the observation period (December 31, 2009). Unexposed women contributed person-time by the same criteria but were excluded from the unexposed cohort at the time of hysterectomy, when they entered the exposed cohort unless the procedure was done for malignant indications. Censoring of exposed was performed if a woman had a primary cancer within 1 year after hysterectomy, if hysterectomy was done for malignant indications, or if a woman had gynecological surgery other than hysterectomy (then the women had an unexposed period until the date of the surgery and then would be censored from the follow-up). A woman without any surgery during follow-up had only an unexposed period.
Data analyses
Crude and age-specific rates were calculated as the number of thyroid cancer cases per 100,000 person-years, with 95% confidence intervals (CIs) based on the Poisson distribution.
Time since start of follow-up was used as time scale in Cox regression, where person time was appropriately assigned to take into account the time dependent nature of the exposure. Cox proportional hazard models were used to
What's new?
The number of women undergoing hysterectomy for benign indications and at a younger age has steadily increased in recent years. However, evidence suggests that the uterus produces compounds other than hormones, including factors involved in cancer pathways. In this large study, the authors found that hysterectomy nearly doubled the risk of developing papillary thyroid cancer. In view of the large number of women worldwide who undergo this surgery every year, the potential long-term risks and adverse effects, including thyroid cancer, should be considered.
estimate hazard ratios (HRs) for thyroid cancer to compare exposed to unexposed patients.
The HR for overall thyroid cancer based on ICD-7 diagnosis for the period 1973-2009, as well as, 1993-2009 (corresponding to the period of morphology based thyroid cancer subtyping) was estimated by stratifying time from surgery (and corresponding dates for the unexposed) in 5-year intervals. The overall risk for thyroid cancer by subtype, based on histological PAD 1993-2009, was estimated without stratification on time from surgery. Attained age, calendar year and parity were modeled and adjusted for as possible confounders, where age was divided into 5-year intervals, calendar year was divided into 10-year periods, and parity was updated during follow-up. To assess the effects of menopause we dichotomized exposed and non-exposed women according to the average age for menopause in Sweden (51 years). 17 We also performed a survival analysis for patients with an ICD-7 diagnosis of thyroid cancer in-between 1973 and 2010. The exposure was hysterectomy versus no hysterectomy before cancer diagnosis and covariates included parity before cancer diagnosis, education and calendar year. The follow-up began on the date of the cancer diagnosis and ended on the earliest date of death, emigration from Sweden and an administrative date of December 31, 2010. Cox proportional hazard models were used to estimate the HR for death among exposed versus unexposed women. The assumption of proportional hazards was verified according to testing based on the Schoenfeld-residual-based statistics. The statistical software package SAS 9.2 (SAS Institute Inc., Cary, NC) was used for all analyses.
Results
The final study population included 90,235 women with hysterectomy (exposed) and 5,379,843 women without hysterectomy (unexposed). The observational period encompassed greater than 55 million person-years and nearly 3,000 cases of thyroid cancer (Table 1) . Demographic data on this cohort has been published in detail previously. 15 The overall incidence rates and hazard ratios for thyroid cancer based on ICD-diagnosis, as well as, rates and risk according to time of exposure are shown in Table 2 . Overall, the rate of thyroid cancer increased by greater than 40% after hysterectomy as compared with those without. This corresponded to a HR of 1.76 (95% CI 1.45-2.14) for the whole period 1973-2009. For the time period 1993-2009 the risk bordered on, but did not reach, statistical significance (HR 1.42, 95% CI 0.91-2.21). The greatest risk for thyroid cancer was observed after 10 years or more, after hysterectomy (HR 1.81, 95% CI 1.32-2.48) whereas in earlier time strata there was no significant association between hysterectomy and a subsequent diagnosis of thyroid cancer based on the ICDdiagnosis for either time period. The incidence rates and adjusted HRs for subtypes based on the histopathological classification (PAD) of thyroid cancer cases 1993-2009 are presented in Table 3 . Of the three categories of thyroid cancer, the incidence rate of papillary thyroid cancer was more than double in exposed women as compared with unexposed women. This corresponded to an adjusted hazard ratio for papillary cancer, which significantly increased among the exposed, as compared with unexposed women (HR 1.70, 95% CI 1.04-2.79). There was no significant association between hysterectomy and follicular carcinoma, or other thyroid cancers (i.e., anaplastic and medullar carcinoma combined), and incidence rates were similar between exposed and unexposed. Table 4 presents the association between hysterectomy and attained age at diagnosis of thyroid cancer based on ICD-diagnosis 1973-2009. Among both exposed and unexposed the majority of thyroid cancer cases occurred in women younger than 60 years of age. Even so there was a clear shift in the occurrence of thyroid cancer toward a lower attained age at the time of diagnosis among the exposed. For exposed women, the adjusted hazard rate of having a diagnosis of thyroid cancer was significantly higher in the age strata 40-49, 50-59 and 60-69 years but not among women 70 years of age. Furthermore, when dichotomizing the study population according to mean age at menopause in Sweden (51 years), the HR of having a pre-menopausal diagnosis of thyroid cancer was significantly higher among the exposed compared with the unexposed (HR 1.86, 95% CI 1.29-2.69).
The overall mortality rates per 100,000 person-years was equal to 1,608.8 (95% CI 766.9-3,374.6) among the exposed and equal to 1,709.5 (95% CI 1,543.7-1,893.1) among nonexposed. Survival-analysis adjusted for educational level and parity showed no significant difference in overall survival when comparing women with thyroid cancer after hysterectomy to those without hysterectomy (HR 1.02, 95% CI 0.48-2.16).
Discussion
The results of this nationwide cohort study suggest that hysterectomy on benign indications increases the overall risk for subsequent clinical thyroid carcinoma. Ascertainment of thyroid cancer subtypes based on histopathology showed an overall incidence rate of papillary thyroid cancer that was more than twice as high after hysterectomy as compared Rate is the crude rate per 100,000 person-years. 1 Other thyroid cancer includes anaplastic and medullar carcinoma adjusted for age at surgery, educational level and parity. 2 The number of study 15 unit and the person years of the follow-up are the same for the three cancer subtypes since we deal with the primary cancers in this article. Comparison with HRs between women with hysterectomy and unexposed in the respective age category. Adjusted for age at hysterectomy, or the corresponding date in non-exposed, educational level and parity.
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with those who did not have the operation. This corresponded to a 70% risk increase after adjustment and strengthens the notion that the positive association between hysterectomy and thyroid cancer is attributed to an increased risk for papillary thyroid cancer in specific. Papillary thyroid cancer is a well-differentiated cancer that comprises about 80-85% of thyroid malignancies with survival rates well above 90% for early stages. The worldwide increase in thyroid cancer incidence since the 1990s is almost entirely attributed to papillary thyroid cancer, 2 and can be related to several factors among which a change in surveillance practice and more active sub-clinical diagnostics has had a large impact. 18, 19 The ideal treatment of small, localized (i.e., low-risk) papillary thyroid cancers has been the subject of controversy and a revision of nomenclature has recently been suggested because of the indolent behavior of these tumors. 20 The ICD-7 nomenclature used in the Cancer Register provides a uniform classification of thyroid cancer but does not allow for subgrouping of thyroid cancer types. For this purpose histopathology is essential. Unfortunately reliable reporting of PAD on a nationwide level was not achieved until the early 1990s and the inability to account for PAD confirmed diagnoses of thyroid cancer subtypes throughout the entire observational period is a limitation of our study. As a consequence we cannot entirely exclude misclassification. However, this possible source of bias would be non-differential, that is, there is no reason to assume that misclassification of thyroid cancer would be more common after hysterectomy as compared with women not having had a hysterectomy. When considering only the ICD-7 diagnosis for thyroid cancer, without subgrouping, there was a robust estimate of increased overall long-term risk of thyroid cancer for a period stretching over more than three decades. In contrast to Luoto et al., 10 the association was not limited to the first 2 years after hysterectomy (which to some extent could be attributed to detection bias) but appeared significantly only a decade after surgery. However, the ICD-7 based risk estimate for overall thyroid cancer was insignificant for the time frame when histological PAD was also available (i.e., 1993-2009). The loss of significance for the association between hysterectomy and thyroid cancer during this period was most likely due to the decreased number of cases available for analysis, that is, insufficient statistical power. For the period 1993-2009 we were nonetheless able to show that hysterectomy carried an increased risk for clinical papillary thyroid cancer in specific. It is reasonable to assume that our results are valid also for earlier years given that the papillary subtype has dominated the occurrence of thyroid cancer subtypes also prior to recent years incidence surge.
Histology and age at diagnosis are important prognostic factors for thyroid cancer. Having a younger age at diagnosis of primary thyroid cancer is generally associated with low risk thyroid cancer. 21, 22 Among women having had a hysterectomy we found a clear shift toward younger attained age at diagnosis of thyroid cancer with significantly higher proportions of women in age groups 40-49 and 50-59 years and fewer in the age category greater than 70 years as compared with women without a previous hysterectomy. At the same time we found no difference in survival between women with thyroid cancer after hysterectomy and those without a previous hysterectomy. Taken together our findings corroborate the assumption that while hysterectomy is associated with an increased risk for clinical papillary thyroid cancer it does not affect long-term survival. Because of the very low mortality due to papillary thyroid cancer, improved understanding of disease progression and individual risk prognostication is important for optimal management. In a recent expert panel statement on the classification of thyroid cancer it was proposed that the non-invasive follicular variant of papillary thyroid cancer represent a distinct class of thyroid tumors with very low risk of adverse outcome which should not be termed cancer. 20 Among our cases diagnosed with papillary thyroid cancer this type of non-invasive, low-risk tumor most certainly was prevalent attenuating the risk of death. This could explain the lack of difference in survival in women with thyroid cancer with and without hysterectomy even though a previous hysterectomy increased the risk of having a thyroid cancer diagnosis in general.
The rationale for the association between hysterectomy and subsequent papillary thyroid cancer is poorly understood. It has been suggested that hysterectomy itself has no biological relationship with the risk for papillary thyroid cancer and acts as a proxy confounder. By this line of reasoning hysterectomy itself has no biological relationship with the risk for papillary thyroid cancer, which instead is a consequence of thyroid dysfunction manifested by bleeding disorders that eventually results in a hysterectomy. 10 In this scenario hysterectomy is not a true confounder but simply serves as an intermediary for the true association. In contrast increasing evidence suggests that the uterus, other than its role in human reproduction, produces a number of factors that may influence various carcinogenic pathways. This notion suggest that hysterectomy might have a direct effect on thyroid cancer pathways by interrupting the synthesis and release of substances able to affect the thyroid gland such as growth factors, substance P and vasoactive peptides. [6] [7] [8] 23 The extent and manner by which these fundamentally different explanation models influence the observed long-term association between hysterectomy and papillary thyroid cancer is unknown.
To the best of our knowledge this is the largest study on the subject to date both with regard to number of ascertained cases and accumulated person-years of follow-up. Recall bias was prevented by the independent prospective data collection and the near-complete registration of available women reduces risk for reporting and ascertainment bias. Censoring was used to remove unknown sources of confounding such as the association between hysterectomy and other malignancies, 24 as well as other types of surgery. Other fortes of our study include the homogenous classification of disease using the ICD-nomenclature; the population based study design; and the ability to analyze PAD in a subpopulation of patients to determine histopathological subtypes of thyroid cancer. The relatively small number of follicular thyroid cases available for analysis did, however, curtail the morphological subanalysis. We also acknowledge that lack of information on usage of hormonal replacement therapy is a limitation of our study. Trends in hysterectomy for benign disorders involves both a widening of indications, as well as, a shift toward performing the operation in women of reproductive and perimenopausal age. 16 Our findings add to the growing body of evidence suggesting that adverse effects of hysterectomy later in life may encompass both benign and malignant diseases. 24, 25 In view of the vast number of women worldwide undergoing hysterectomy for benign disorders every year, associated long-term risks including thyroid cancer should be considered before surgery.
Conclusion
Hysterectomy on benign indications is associated with an increased risk for thyroid cancer and papillary thyroid cancer in specific. After hysterectomy women had a younger attained age at diagnosis of thyroid cancer but no difference in survival when compared with women with thyroid cancer but no previous hysterectomy.
